F.L. Putnam Investment Management’s Mustang Bio MBIO Stock Holding History

F.L. Putnam Investment Management’s Portfolio MBIO Stock Details MBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-27	Closed	-$7.3K	–	472
2023 Q1	$7.3K	Hold	27	–	–	﹤0.01%	419
2022 Q4	$7.87K	Sell	27 -6	-18%	-$2.05K	﹤0.01%	402
2022 Q3	$12K	Hold	33	–	–	﹤0.01%	390
2022 Q2	$15K	Hold	33	–	–	﹤0.01%	398
2022 Q1	$25K	Hold	33	–	–	﹤0.01%	408
2021 Q4	$41K	Hold	33	–	–	﹤0.01%	408
2021 Q3	$67K	Buy	+33	New	+$70.9K	﹤0.01%	404

Other funds holding MBIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KOC

Koss-Olinger Consulting Gainesville, Florida $1.19B AUM 15.91% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

F.L. Putnam Investment Management's MBIO Position: Q2 2023 in Review

F.L. Putnam Investment Management sold out of Mustang Bio (MBIO) in Q2 2023, closing a stake of 27 shares — an estimated $7.3K sold.

F.L. Putnam Investment Management first reported a position in MBIO in Q3 2021 and held it in 7 quarters. The position peaked at $67K in Q3 2021. 27 funds tracked by Wall St. Rank hold MBIO as of Q2 2023.

F.L. Putnam Investment Management reported no remaining Mustang Bio position as of Q2 2023 after selling out during the quarter.
F.L. Putnam Investment Management sold 27 Mustang Bio shares in Q2 2023, an estimated $7.3K.
F.L. Putnam Investment Management first reported a position in Mustang Bio in Q3 2021 and held it in 7 quarters.
F.L. Putnam Investment Management's Mustang Bio position peaked at $67K in Q3 2021.
27 funds tracked by Wall St. Rank held Mustang Bio as of Q2 2023.

Based on F.L. Putnam Investment Management's 13F filing for Q2 2023, filed 14 Aug 2023.